According to the company, the barcode on the overwrap is correct but the primary container barcode could be mislabeled with the barcode for Heparin Sodium 2000 USP units/1000mL in 0.9% Sodium Chloride injection.
Packaged in 50/100mL container bags and sold 24 bags per carton, the lot was distributed nationwide from October 2014 to January 2015 to wholesalers, distributors and hospitals in the US.
The prescription-based product is administered intravenously to prevent and control seizures in preeclampsia and eclampsia, respectively.
So far, Hospira has not received reports of any adverse events related with this issue for this lot.
An investigation has been already launched by Hospira to find out the root cause and take corrective and preventive actions.